2015 was yet again a very satisfying year for EUROIMMUN, as announced at the Annual Meeting of Shareholders on 8 July 2016. This year, around 750 shareholders assisted the meeting, which is a new record. With an increase of 17.5%, the Group turnover exceeded the threshold of 200 million euros for the first time (amounting […]
A few days ago the “Sächsische Aufbaubank”, the central development agency of the Free State of Saxony, granted the funding of the joint research project EUROPure of EUROIMMUN and the University of Applied Sciences of Zittau/Görlitz. The project aims at the joint development of a robust technology platform permitting cost-efficient and resource-friendly preparation of proteins
2014 was once again a successful business year for EUROIMMUN Medizinische Labordiagnostika AG, as the supervisory board and the board of directors of the company could report to the 260 shareholders at the General Meeting on 10th July 2015. The company’s turnover increased by 24.4 % compared to the previous year to over 134.1 million
The company ranks among the top 10 of German small and medium-sized enterprises EUROIMMUN AG, manufacturer and distributor of laboratory diagnostics since 1987, has been ranked for the 3rd time amongst the top 10 German SMEs by the Munich Strategy Group. According to MSG, the company is one of the leaders of the German Mittelstand
A new production site joined the existing branches of EUROIMMUN in Northern Germany: Just a few days ago, the first employees moved to their new workplace in Selmsdorf (Mecklenburg-Western Pomerania). At the end of March, EUROIMMUN bought the former business premises of the insolvent company Ladenbau Johann Weiman GmbH – and therewith, gained additional 12,000
